Randomized phase III study comparing gefitinib (G) with erlotinib (E) in patients (pts) with previously treated advanced lung adenocarcinoma (LA): WJOG 5108L.Nobuyuki Katakami, Satoshi Morita, Hiroshige Yoshioka et al.|Journal of Clinical Oncology|2014Cited by 11